Industry Symposium 16

  
13:30-15:00 Capital Suite 2-3-4

Steps Forward: Fabry Disease in Nephrology

Chair: Alberto Ortiz, Madrid, Spain
 

Occurence Of Severe Clinical Events by time On Agalsidase Beta among Patients with Fabry Disease
Alberto Ortiz, Madrid, Spain
FAbry STabilization indEX (FASTEX)
Renzo Mignani, Rimini, Italy
Ten-year outcome of Enzyme Replacement Therapy with Agalsidase Beta in Patients with Fabry Disease
Dominique P. Germain, Paris, France

Organised by GENZYME

 

back to the timetable